Certara, Inc. 700.HM Stock
Certara, Inc. Price Chart
Certara, Inc. 700.HM Financial and Trading Overview
Certara, Inc. stock price | 15.77 EUR |
Previous Close | 16.3 EUR |
Open | 16 EUR |
Bid | 16.1 EUR x N/A |
Ask | 16.3 EUR x N/A |
Day's Range | 16 - 16 EUR |
52 Week Range | 10.6 - 23.4 EUR |
Volume | 200 EUR |
Avg. Volume | 9 EUR |
Market Cap | 2.68B EUR |
Beta (5Y Monthly) | 1.57484 |
PE Ratio (TTM) | 200 |
EPS (TTM) | -0.33 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 37.75 EUR |
700.HM Valuation Measures
Enterprise Value | 2.6B EUR |
Trailing P/E | 200 |
Forward P/E | 47.058823 |
PEG Ratio (5 yr expected) | 4.38 |
Price/Sales (ttm) | 7.78736 |
Price/Book (mrq) | 2.3571007 |
Enterprise Value/Revenue | 7.548 |
Enterprise Value/EBITDA | 29.169 |
Trading Information
Certara, Inc. Stock Price History
Beta (5Y Monthly) | 1.57484 |
52-Week Change | -4.79% |
S&P500 52-Week Change | 20.43% |
52 Week High | 23.4 EUR |
52 Week Low | 10.6 EUR |
50-Day Moving Average | 20.15 EUR |
200-Day Moving Average | 16.69 EUR |
700.HM Share Statistics
Avg. Volume (3 month) | 9 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 159.83M |
Float | 105.02M |
Short Ratio | N/A |
% Held by Insiders | 3.27% |
% Held by Institutions | 89.79% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 4.03% |
Operating Margin (ttm) | 10.47% |
Gross Margin | 60.90% |
EBITDA Margin | 25.87% |
Management Effectiveness
Return on Assets (ttm) | 1.46% |
Return on Equity (ttm) | 1.30% |
Income Statement
Revenue (ttm) | 344.39M EUR |
Revenue Per Share (ttm) | 2.19 EUR |
Quarterly Revenue Growth (yoy) | 10.69% |
Gross Profit (ttm) | 203.07M EUR |
EBITDA | 89.12M EUR |
Net Income Avi to Common (ttm) | 13.88M EUR |
Diluted EPS (ttm) | 0.08 |
Quarterly Earnings Growth (yoy) | -38.60% |
Balance Sheet
Total Cash (mrq) | 248.4M EUR |
Total Cash Per Share (mrq) | 1.55 EUR |
Total Debt (mrq) | 306.62M EUR |
Total Debt/Equity (mrq) | 28.26 EUR |
Current Ratio (mrq) | 3.712 |
Book Value Per Share (mrq) | 6.788 |
Cash Flow Statement
Operating Cash Flow (ttm) | 92.7M EUR |
Levered Free Cash Flow (ttm) | 87.24M EUR |
Profile of Certara, Inc.
Country | Germany |
State | NJ |
City | Princeton |
Address | 100 Overlook Center |
ZIP | 08540 |
Phone | 609 716 7900 |
Website | https://www.certara.com |
Industry | Health Information Services |
Sector(s) | Healthcare |
Full Time Employees | 1150 |
Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Australia, Canada, China, France, Germany, India, Italy, Japan, Luxembourg, the Netherlands, the Philippines, Poland, Portugal, Spain, Switzerland, and the United Kingdom. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
Q&A For Certara, Inc. Stock
What is a current 700.HM stock price?
Certara, Inc. 700.HM stock price today per share is 15.77 EUR.
How to purchase Certara, Inc. stock?
You can buy 700.HM shares on the Hamburg exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Certara, Inc.?
The stock symbol or ticker of Certara, Inc. is 700.HM.
Which industry does the Certara, Inc. company belong to?
The Certara, Inc. industry is Health Information Services.
How many shares does Certara, Inc. have in circulation?
The max supply of Certara, Inc. shares is 171.67M.
What is Certara, Inc. Price to Earnings Ratio (PE Ratio)?
Certara, Inc. PE Ratio is now.
What was Certara, Inc. earnings per share over the trailing 12 months (TTM)?
Certara, Inc. EPS is -0.33 EUR over the trailing 12 months.
Which sector does the Certara, Inc. company belong to?
The Certara, Inc. sector is Healthcare.